Message Font: Serif | Sans-Serif
 
No. of Recommendations: 5
Nice article Rich!

One minor point that I was discussing in a prior post (http://boards.fool.com/Message.asp?mid=21629244). You said in your article: "Despite being the market leader, CNS saw last quarter's Breathe Right sales falter, falling 5% with earnings down $0.05 a share from a year ago." This is true, but perhaps easy to misunderstand.

By way of clarification the sales that "faltered" were actually in the "Vapor Shot" product line (which is still a "Breathe Right" product but not to be confused with the nasal strips). From the Form 10-Q: "Breathe Right brand sales decreased by $1.1 million dollars primarily as the result of the 2003 comparable quarter including new product pipeline shipments of Vapor Shot! personal vaporizer." In other words fluctuations in sales levels were due in part to timing of distributor purchases filling up the pipeline last year.

Just wanted to mention this so people don't think sales of the nasal strips are faltering. Thanks again for the good article.

--Bill
long CNXS
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.